D. Stoppa-Lyonnet

发表

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

V. Pankratz, F. Couch, B. Bonanni, 2012, British Journal of Cancer.

Exploring the link between MORF4L1 and risk of breast cancer

S. Seal, N. Rahman, F. Couch, 2011, Breast Cancer Research.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Genetics.

Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition

I. Bièche, V. Chabaud, J. Peyrat, 2012, Breast Cancer Research and Treatment.

Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes

L. Desjardins, D. Stoppa-Lyonnet, B. Bressac-de Paillerets, 2000, British Journal of Cancer.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

Inactivation of the ATM gene in T-cell prolymphocytic leukemias.

F. Sigaux, J. Soulier, M. Stern, 1998, Blood.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Sebastian M. Armasu, Jaana M. Hartikainen, A. Whittemore, 2013, Nature Genetics.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Sandra L. Halverson, A. Whittemore, L. Kiemeney, 2016, Gynecologic oncology.

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

A. Ashworth, A. Vincent-Salomon, D. Stoppa-Lyonnet, 2010, British Journal of Cancer.

Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.

P. Oefner, T. Wagner, T. Sandberg, 1999, Genomics.

Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction.

P. Devilee, C. V. van Asperen, B. Wappenschmidt, 2023, Breast.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

V. Pankratz, F. Couch, T. Rebbeck, 2011, Human molecular genetics.

q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers

V. Pankratz, F. Couch, B. Bonanni, 2012 .

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Stefania Tommasi, Laura Cortesi, Mads Thomassen, 2019, Cancer research.

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide

Ivana K. Kim, S. Puig, N. Hayward, 2018, Journal of the National Cancer Institute.

germline mutations in women with familial breast cancer and a relative with haematological malignancy

J. Viovy, L. Paglia, J. Weber, 2023 .

Comparing ataxias with oculomotor apraxia: a multimodal study of AOA1, AOA2 and AT focusing on video-oculography and alpha-fetoprotein

M. Vidailhet, B. Gaymard, D. Grabli, 2017, Scientific Reports.

Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees

S. Vacher, I. Bièche, V. Bécette, 2023, Journal of Medical Genetics.

Stability of microsatellites and minisatellites in Bloom syndrome, a human syndrome of genetic instability.

J. Buard, M. Amor-Guéret, Frédéric Foucault, 1996, Mutation research.

Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype.

N. Mahlaoui, J. Pedespan, B. Neven, 2011, The Journal of allergy and clinical immunology.

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma

J. Limacher, M. Barrois, A. Chompret, 2008, British Journal of Cancer.

Truncation at conserved terminal regions of BRCA1 protein is associated with highly proliferating hereditary breast cancers.

D. Birnbaum, J. Peyrat, D. Stoppa-Lyonnet, 1996, Cancer research.

Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee.

D. Stoppa-Lyonnet, H. Sobol, J. Feingold, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition

Eliseos J. Mucaki, F. Lallemand, I. Bièche, 2018, Breast Cancer Research and Treatment.